Alnylam Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
2,100
Employees2,100
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
2,100
Employees2,100

ALNY Key Statistics

Market cap
32.26B
Market cap32.26B
Price-Earnings ratio
-94.91
Price-Earnings ratio-94.91
Dividend yield
—
Dividend yield—
Average volume
996.39K
Average volume996.39K
High today
$250.68
High today$250.68
Low today
$246.26
Low today$246.26
Open price
$249.41
Open price$249.41
Volume
197.66K
Volume197.66K
52 Week high
$304.39
52 Week high$304.39
52 Week low
$141.98
52 Week low$141.98

ALNY News

TipRanks 4d
Alnylam Pharmaceuticals announces interim Phase 1 data of nucresiran

Alnylam (ALNY) Pharmaceuticals announced the presentation of new results from its Phase 1 study of nucresiran, a next-generation RNAi therapeutic in development...

Analyst ratings

70%

of 33 ratings
Buy
69.7%
Hold
24.2%
Sell
6.1%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.